MM
Therapeutic Areas
Arcturus Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KOSTAIVE® (ARCT-154) | COVID-19 | Approved |
| LUNAR®-OTC (ARCT-810) | Ornithine Transcarbamylase Deficiency | Phase 2 |
| LUNAR®-CF (ARCT-032) | Cystic Fibrosis | Phase 2 |
| LUNAR®-FLU (ARCT-2304) | Pandemic Influenza (H5N1) | Phase 1 |
| LUNAR®-FLU (ARCT-2138) | Seasonal Influenza | Phase 1 |
Leadership Team at Arcturus Therapeutics
JE
Joseph E. Payne
President, Chief Executive Officer, Co-Founder, Director
PC
Pad Chivukula
Chief Scientific Officer, Chief Operating Officer
AS
Andy Sassine
Chief Financial Officer
SS
Steve Sabo
Chief Executive Officer of ARCALIS
PF
Peter Farrell
Chairman of the Board